HomeCompareJPPYY vs MRK

JPPYY vs MRK: Dividend Comparison 2026

JPPYY yields 500000.00% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JPPYY wins by $252475121624236192.00M in total portfolio value
10 years
JPPYY
JPPYY
● Live price
500000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$252475121624236192.00M
Annual income
$179,970,099,914,313,700,000,000.00
Full JPPYY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — JPPYY vs MRK

📍 JPPYY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodJPPYYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, JPPYY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
JPPYY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

JPPYY
Annual income on $10K today (after 15% tax)
$42,500,000.00/yr
After 10yr DRIP, annual income (after tax)
$152,974,584,927,166,630,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, JPPYY beats the other by $152,974,584,927,166,630,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of JPPYY + MRK for your $10,000?

JPPYY: 50%MRK: 50%
100% MRK50/50100% JPPYY
Portfolio after 10yr
$126237560812118096.00M
Annual income
$89,985,049,957,156,840,000,000.00/yr
Blended yield
71.28%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

JPPYY
No analyst data
Altman Z
0.3
Piotroski
2/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

JPPYY buys
0
MRK buys
0
No recent congressional trades found for JPPYY or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricJPPYYMRK
Forward yield500000.00%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%32.7%
Portfolio after 10y$252475121624236192.00M$56.8K
Annual income after 10y$179,970,099,914,313,700,000,000.00$9,798.13
Total dividends collected$246974404501167104.00M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: JPPYY vs MRK ($10,000, DRIP)

YearJPPYY PortfolioJPPYY Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$25,010,700$25,000,000.00$11,206$366.19+$25.00MJPPYY
2$29,244,868,926$29,218,107,476.64$12,650$502.35+$29244.86MJPPYY
3$15,996,042,711,578$15,964,750,701,827.40$14,407$694.19+$15996042.70MJPPYY
4$4,097,595,673,237,753$4,080,479,907,536,365.00$16,585$967.82+$4097595673.22MJPPYY
5$492,827,571,123,448,100$488,443,143,753,083,800.00$19,342$1,363.89+$492827571123.43MJPPYY
6$27,978,829,179,189,830,000$27,451,503,678,087,737,000.00$22,913$1,947.19+$27978829179189.80MJPPYY
7$758,198,099,371,876,500,000$728,260,752,150,143,400,000.00$27,662$2,823.89+$758198099371876.50MJPPYY
8$10,033,296,784,320,553,000,000$9,222,024,817,992,646,000,000.00$34,159$4,173.35+$10033296784320554.00MJPPYY
9$67,761,702,532,637,870,000,000$57,026,074,973,414,870,000,000.00$43,337$6,308.80+$67761702532637872.00MJPPYY
10$252,475,121,624,236,200,000,000$179,970,099,914,313,700,000,000.00$56,776$9,798.13+$252475121624236192.00MJPPYY

JPPYY vs MRK: Complete Analysis 2026

JPPYYStock

Jupai Holdings Limited, together with its subsidiaries, provides wealth management products and advisory services to high-net-worth individuals in China. It offers services for fixed income products, private equity and venture capital funds, and public market products, as well as other products, including overseas insurance products and foreign-currency denominated alternative investments. The company also provides asset management services, including management of real estate or related funds and other fund products. In addition, it offers fund management services, as well as advisory and administrative services. As of December 31, 2021, it operated 22 client centers in 22 cities in Mainland China and Hong Kong. The company was formerly known as Jupai Investment Group and changed its name to Jupai Holdings Limited in December 2014. Jupai Holdings Limited was founded in 2010 and is headquartered in Shanghai, China.

Full JPPYY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this JPPYY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

JPPYY vs SCHDJPPYY vs JEPIJPPYY vs OJPPYY vs KOJPPYY vs MAINJPPYY vs JNJJPPYY vs ABBVJPPYY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.